Showing 1 - 20 results of 95 for search '"pharmaceutical company"', query time: 0.07s Refine Results
  1. 1
  2. 2

    EFFECT OF E-RECRUITMENT ON THE GROWTH OF PHARMACEUTICAL COMPANIES IN ILORIN, KWARA STATE by Nurudeen Bello Ahmed, Rabiat Omoshalewa Bashir

    Published 2023-11-01
    “…This study focused on examining the effect of e-Recruitment on the growth of pharmaceutical companies in Ilorin, Kwara State. The study employed survey research design through the use of self-administered questionnaire. …”
    Get full text
    Article
  3. 3
  4. 4

    FIRM’S CHARACTERISTICS AND EARNINGS MANAGEMENT: EVIDENCE FROM LISTED PHARMACEUTICAL COMPANIES IN NIGERIA by Muhammed BELLO, Leye Sherifdeen OYEDIRAN, Emmanuel Yinka ONIFADE

    Published 2023-12-01
    “…The population of this study consists of all listed pharmaceutical companies on the floor of the Nigeria Stock Exchange as at 31st December, 2021. …”
    Get full text
    Article
  5. 5
  6. 6

    Analysis of Three Penicillin Antibiotics (Ampicillin, Amoxicillin and Cloxacillin) of Several Iranian Pharmaceutical Companies by HPLC by A. Ashnagar, N. Gharib Naseri

    Published 2007-01-01
    “…In this research the purity of the standard active ingredients of the various dosage forms of three penicillins (Amoxicillin, Cloxacillin and Ampicillin) imported and the purity percentage of the active ingredients in each of the various dosage forms of these drugs manufactured by several pharmaceutical companies of Iran (Kosar, Farabi and Jaber Ibn Hayan) were investigated and determined by HPLC technique. …”
    Get full text
    Article
  7. 7

    Quality Assessment of Hydroxychloroquine Tablet: A Comparative Evaluation of Drug Produced by Different Pharmaceutical Companies in Bangladesh by Md. Raihanur Islam, Md. Sakhawat Hossain, Md. Sanower Hossain, Mohammad Touhidul Islam, Sharifa Sultana, Nisarat Nijhum, Kutub Uddin Ahamed, Chee-Yan Choo, Ching Siang Tan, Khang Wen Goh

    Published 2023-07-01
    “…Therefore, this study examined the quality of hydroxychloroquine produced by Bangladeshi pharmaceutical companies, concentrating on quality control parameters: the assay, dissolution, disintegration, hardness, friability, and weight fluctuation. …”
    Get full text
    Article
  8. 8

    Internal Communication in Pharmaceutical Companies: A Case Study of Portuguese Companies during the Pandemic of COVID-19 by Andreia Garcia

    Published 2025-01-01
    “…This research examines how the COVID-19 pandemic influenced employee communication practices within pharmaceutical companies operating in Portugal. Through a survey of communication managers, our findings reveal that these companies not only shifted to online communication channels during the pandemic but continue to maintain these digital platforms as primary communication tools. …”
    Get full text
    Article
  9. 9

    Association between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis. by Hneine Brax, Racha Fadlallah, Lina Al-Khaled, Lara A Kahale, Hala Nas, Fadi El-Jardali, Elie A Akl

    Published 2017-01-01
    “…<h4>Background</h4>Pharmaceutical company representatives likely influence the prescribing habits and professional behaviors of physicians. …”
    Get full text
    Article
  10. 10

    Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016 by Marlene Stoll, Lara Hubenschmid, Cora Koch, Klaus Lieb

    Published 2020-09-01
    “…Objective To analyse voluntary payment reports of pharmaceutical companies to German healthcare professionals (HCPs) in 2015 and 2016 based on an industry-self-regulating transparency codex.Design and participants Cohort study of all German HCPs who voluntarily agreed that at least one payment they received in 2015 and 2016 from pharmaceutical companies is disclosed.Main outcome measures Number of HCPs who disclosed at least one payment in the database; separated by year of disclosure and whether they disclosed once or repeatedly. …”
    Get full text
    Article
  11. 11
  12. 12

    Physicians’ attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey by Marlene Stoll, Lara Hubenschmid, Cora Koch, Klaus Lieb, Boris Egloff

    Published 2022-06-01
    “…Objectives To investigate German physicians’ attitudes towards and experiences with voluntary disclosure of payments by pharmaceutical companies in a public database and their impact on future decisions for or against disclosure.Design A national cross-sectional survey conducted in 2018 among physicians who voluntarily disclosed at least one payment in the German transparency regulation.Setting Retrospective paper-pencil questionnaire about attitudes towards and experiences with voluntary payment disclosures in the first (2015) and second (2016) years of the German transparency regulation.Participants German physicians who disclosed either in the first year only, the second year only, or in both years of the transparency regulation.Primary outcomes (1) The probability to disclose in 2016, predicted by physicians’ experience of reactions from others in 2015, descriptive norms and attitudes towards transparency; (2) Frequency and (3) Content of reactions from others in 2015 compared with 2016.Results Data of 234 respondents were analysed (n=42, 45 and 147 physicians who disclosed in 2015, 2016 or both years, respectively). …”
    Get full text
    Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Ranking of companies in generating operating cash flows based on data envelopment analysis by Leila Negahban, Bahman Banimahd, Seyed Hosseini, Azam Shokri Cheshmeh Sabzi

    Published 2023-12-01
    “…The results of this research show that Farabi pharmaceutical company has the highest efficiency score in creating Operating Cash Flows (OCFs) and Loqman pharmaceutical company has the lowest efficiency score. …”
    Get full text
    Article
  19. 19

    The impact of headache specialist density and the introduction of gepants and lasmitidan on prescriptions for acute migraine treatments: a regression and interrupted time series an... by Leon S. Moskatel, Rebecca Y. Linfield, Niushen Zhang

    Published 2025-02-01
    “…Critically, there was a strong association between a pharmaceutical company’s, Pfizer, payments to physicians and utilization of their medication, rimegepant.…”
    Get full text
    Article
  20. 20